In the latest session, Fractyl Health Inc. (NASDAQ: GUTS) closed at $7.40 up 2.78% from its previous closing price of $7.20. In other words, the price has increased by $+0.20 from its previous closing price. On the day, 244392 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Fractyl Health Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.57 and its Current Ratio is at 5.57.
On February 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $18.
On February 27, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $26.BofA Securities initiated its Buy rating on February 27, 2024, with a $26 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 06 ’24 when Elia Marc bought 466,666 shares for $15.00 per share. The transaction valued at 6,999,990 led to the insider holds 1,856,117 shares of the business.
CVF, LLC bought 333,333 shares of GUTS for $4,999,995 on Feb 06 ’24. The 10% Owner now owns 4,673,870 shares after completing the transaction at $15.00 per share. On Feb 06 ’24, another insider, Mithril LP, who serves as the 10% Owner of the company, bought 333,333 shares for $15.00 each. As a result, the insider paid 4,999,995 and bolstered with 1,251,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GUTS now has a Market Capitalization of 344.20M and an Enterprise Value of 355.21M. Its current Enterprise Value per Revenue stands at 3.14k whereas that against EBITDA is -7.26.
Stock Price History:
Over the past 52 weeks, GUTS has reached a high of $14.50, while it has fallen to a 52-week low of $5.92. The 50-Day Moving Average of the stock is 8.45, while the 200-Day Moving Average is calculated to be 8.45.
Shares Statistics:
For the past three months, GUTS has traded an average of 488.90K shares per day and 269.3k over the past ten days. A total of 47.61M shares are outstanding, with a floating share count of 22.26M. Insiders hold about 53.25% of the company’s shares, while institutions hold 3.90% stake in the company. Shares short for GUTS as of Mar 15, 2024 were 3.43M with a Short Ratio of 7.02, compared to 1.03M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.21% and a Short% of Float of 7.43%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.34 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.51 and -$1.51 for the fiscal current year, implying an average EPS of -$1.51. EPS for the following year is -$1.89, with 1 analysts recommending between -$1.89 and -$1.89.
